Clinical trial Recruiting at 2 sites Interventional Ages 45 to 60

VisAbility Micro Insert System for Presbyopia

Official title: A Prospective, Multicenter Clinical Trial To Evaluate The Safety And The Improvement In Near Visual Acuity In Presbyopic Patients Treated With The VisAbility™ Micro Insert System Through 12 Months

Run by VisDura, Inc. · NCT07637500 · Data updated 2026-11-12

A new device called the VisAbility Micro Insert System is being tested to see if it can improve near vision at reading distance for adults with presbyopia.

Quick facts

Study typeInterventional
Ages45 Years to 60 Years
SexAll
Enrollment33 (estimated)
SponsorVisDura, Inc.
Industry-sponsored
Locations2 sites (Bochum and 1 other locations)
StatusRecruiting
StartedJune 2, 2026
Main results expectedDecember 2027
Study endsDecember 2027
Registry record updatedOctober 15, 2026
Trial IDNCT07637500 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 45–60 with 20/20 distance vision in both eyes and poor near vision at 40 cm in both eyes.

Probably not a fit

Individuals with ocular inflammation, inflammatory eye disease, autoimmune conditions, or significant iris/pupillary differences may not benefit and could be excluded.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study evaluates the VisAbility Micro Insert System in presbyopic adults. Eligible participants are 45 to 60 years old with perfect distance vision in both eyes and reduced near vision at 40 cm. The trial focuses on safety and the ability of the device to improve binocular distance-corrected near visual acuity. No phase information is provided. It is conducted at two European eye centers with VisDura, Inc. as the sponsor.

Why it matters

Potential benefit: If successful, participants may experience better clarity at near reading distances with improved binocular near vision.

How similar studies have gone: Previous similar approaches in vision correction have shown mixed results; this specific device trial is a novel application awaiting outcomes.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Subjects must be between ages of 45 to 60 at the time of enrolment.
2. Subjects must have best corrected distance visual acuity (BCDVA) of 20/20 in each eye.
3. Subjects must have distance corrected near visual acuity (DCNVA) @ 40 cm of 20/50, 20/63 or 20/80 in each eye.
4. Subjects must have binocular distance corrected near visual acuity (DCNVA) @ 40 cm of 20/50, 20/63 or 20/80.

Exclusion Criteria:

1. Subjects where either pupil has a baseline percent change from scotopic to photopic of less than 30% or an absolute difference of less than 1.00 mm between scotopic and photopic pupil size as measured by the NeurOptics Pupillometer.
2. Subjects with ocular inflammation, chronic uveitis, or other recurrent anterior or posterior segment inflammatory conditions in either eye; subjects with any ocular or systemic disease(s) posting a significant risk for ocular inflammation, including but not limited to autoimmune disorders (e.g., rheumatoid arthritis, ankylosing spondylitis, Reiter's syndrome, ulcerative colitis, Crohn's disease, psoriasis, sarcoidosis, Behcet's disease), infections (toxoplasmosis, cat-scratch fe ver, West Nile virus, syphilis, tuberculosis, herpes zoster, herpes simplex, adenovirus), ocular trauma, or gout.
3. Subjects with scleral thickness of less than 530 microns as measured 3.5 to 4.0 mm posterior to the superior temporal quadrant limbus in either eye.
4. Subjects with a history of any prior intraocular procedure (e.g., corneal transplant, filtering procedures for glaucoma, vitrectomy, retinal detachment repair, cataract surgery) or any prior refractive procedure (e.g. LASIK, surface excimer, or incisional surgery) in either eye.

Where it's running

  • Ruhr University Eye Hospital
    Bochum, Germany
    Recruiting
  • Universitäts-Augenklinik Heidelberg
    Heidelberg, Germany
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.